There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 2

Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
Authors: Howard W. Thom, Jeroen Jansen, Jason Shafrin …
Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar’s healthcare perspective
Authors: Ahmad M Adel, Dina Abushanab, Daoud Al-Badriyeh …

See all cited by

Phase 3 study of L-glutamine in sickle cell disease: analyses of time to first and second crisis and average cumulative recurrent events

Read this article at

Related collections

Remedies to the replicability crisis

Comments

Comment on this article

Similar content 1,494

Cited by 2